{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T12:42:28Z","timestamp":1793882548819,"version":"4.7.0"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2024,1,20]],"date-time":"2024-01-20T00:00:00Z","timestamp":1705708800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,1,20]],"date-time":"2024-01-20T00:00:00Z","timestamp":1705708800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"Sichuan Science and Technology Program","award":["2022YFS0048"],"award-info":[{"award-number":["2022YFS0048"]}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81970481"],"award-info":[{"award-number":["81970481"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"1.3.5 project for disciplines of excellence, West China Hospital, Sichuan University","award":["2020HXFH047"],"award-info":[{"award-number":["2020HXFH047"]}]},{"name":"1.3.5 project for disciplines of excellence, West China Hospital, Sichuan University","award":["20HXJS005"],"award-info":[{"award-number":["20HXJS005"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Surg Oncol"],"published-print":{"date-parts":[[2024,6]]},"DOI":"10.1245\/s10434-024-14936-3","type":"journal-article","created":{"date-parts":[[2024,1,20]],"date-time":"2024-01-20T19:41:05Z","timestamp":1705779665000},"page":"3819-3829","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["Impact of Skeletal Muscle Loss and Sarcopenia on Outcomes of Locally Advanced Esophageal Cancer during Neoadjuvant Chemoradiation"],"prefix":"10.1245","volume":"31","author":[{"given":"Xin","family":"Xiao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pin-Hao","family":"Fang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jian-Feng","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao-Kun","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qi-Xin","family":"Shang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu-Shang","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Si-Yuan","family":"Luan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Long-Qi","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yong","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,1,20]]},"reference":[{"key":"14936_CR1","doi-asserted-by":"publisher","first-page":"873","DOI":"10.1016\/j.semcancer.2022.01.007","volume":"86","author":"X Li","year":"2022","unstructured":"Li X, Chen L, Luan S, et al. The development and progress of nanomedicine for esophageal cancer diagnosis and treatment. Semin Cancer Biol. 2022;86:873\u201385.","journal-title":"Semin Cancer Biol."},{"issue":"7","key":"14936_CR2","doi-asserted-by":"publisher","first-page":"855","DOI":"10.6004\/jnccn.2019.0033","volume":"17","author":"JA Ajani","year":"2019","unstructured":"Ajani JA, D\u2019Amico TA, Bentrem DJ, et al. Esophageal and esophagogastric junction cancers, Version 2.2019, NCCN clinical practice guidelines in oncology. J Natl Compr Canc Netw. 2019;17(7):855\u201383.","journal-title":"J Natl Compr Canc Netw."},{"issue":"18","key":"14936_CR3","doi-asserted-by":"publisher","first-page":"1995","DOI":"10.1200\/JCO.20.03614","volume":"39","author":"BM Eyck","year":"2021","unstructured":"Eyck BM, van Lanschot JJB, Hulshof M, et al. Ten-year outcome of neoadjuvant chemoradiotherapy plus surgery for esophageal cancer: the randomized controlled CROSS Trial. J Clin Oncol: Offic J Am Soc Clin Oncol. 2021;39(18):1995\u20132004.","journal-title":"J Clin Oncol: Offic J Am Soc Clin Oncol."},{"issue":"8","key":"14936_CR4","doi-asserted-by":"publisher","first-page":"4530","DOI":"10.1245\/s10434-020-09549-5","volume":"28","author":"K Kano","year":"2021","unstructured":"Kano K, Yamada T, Yamamoto K, et al. The impact of pretherapeutic naples prognostic score on survival in patients with locally advanced esophageal cancer. Ann Surg Oncol. 2021;28(8):4530\u20139.","journal-title":"Ann Surg Oncol."},{"issue":"2","key":"14936_CR5","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1245\/s10434-015-4869-5","volume":"23","author":"H Yodying","year":"2016","unstructured":"Yodying H, Matsuda A, Miyashita M, et al. Prognostic significance of neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio in oncologic outcomes of esophageal cancer: a systematic review and meta-analysis. Ann Surg Oncol. 2016;23(2):646\u201354.","journal-title":"Ann Surg Oncol."},{"issue":"6","key":"14936_CR6","doi-asserted-by":"publisher","first-page":"1408","DOI":"10.1002\/jcsm.12831","volume":"12","author":"J McGovern","year":"2021","unstructured":"McGovern J, Dolan RD, Horgan PG, Laird BJ, McMillan DC. Computed tomography-defined low skeletal muscle index and density in cancer patients: observations from a systematic review. J Cachexia Sarcopenia Muscle. 2021;12(6):1408\u201317.","journal-title":"J Cachexia Sarcopenia Muscle."},{"issue":"5","key":"14936_CR7","doi-asserted-by":"publisher","first-page":"e311","DOI":"10.1097\/SLA.0000000000005452","volume":"276","author":"UM Jogiat","year":"2022","unstructured":"Jogiat UM, Sasewich H, Turner SR, et al. Sarcopenia determined by skeletal muscle index predicts overall survival, disease-free survival, and postoperative complications in resectable esophageal cancer: a systematic review and meta-analysis. Ann Surg. 2022;276(5):e311\u20138.","journal-title":"Ann Surg."},{"issue":"12","key":"14936_CR8","doi-asserted-by":"publisher","first-page":"7185","DOI":"10.1245\/s10434-021-10025-x","volume":"28","author":"T Ishida","year":"2021","unstructured":"Ishida T, Makino T, Yamasaki M, et al. Quantity and quality of skeletal muscle as an important predictor of clinical outcomes in patients with esophageal cancer undergoing esophagectomy after neoadjuvant chemotherapy. Ann Surg Oncol. 2021;28(12):7185\u201395.","journal-title":"Ann Surg Oncol."},{"issue":"5","key":"14936_CR9","doi-asserted-by":"publisher","first-page":"822","DOI":"10.1097\/SLA.0000000000002398","volume":"266","author":"JA Elliott","year":"2017","unstructured":"Elliott JA, Doyle SL, Murphy CF, et al. Sarcopenia: prevalence, and impact on operative and oncologic outcomes in the multimodal management of locally advanced esophageal cancer. Ann Surg. 2017;266(5):822\u201330.","journal-title":"Ann Surg."},{"issue":"6","key":"14936_CR10","doi-asserted-by":"publisher","first-page":"1100","DOI":"10.1097\/SLA.0000000000002252","volume":"267","author":"Y Nakashima","year":"2018","unstructured":"Nakashima Y, Saeki H, Nakanishi R, et al. Assessment of sarcopenia as a predictor of poor outcomes after esophagectomy in elderly patients with esophageal cancer. Ann Surg. 2018;267(6):1100\u20134.","journal-title":"Ann Surg."},{"issue":"9","key":"14936_CR11","doi-asserted-by":"publisher","first-page":"2894","DOI":"10.1007\/s00268-018-4554-5","volume":"42","author":"H Saeki","year":"2018","unstructured":"Saeki H, Nakashima Y, Kudou K, et al. Neoadjuvant chemoradiotherapy for patients with cT3\/nearly T4 esophageal cancer: is sarcopenia correlated with postoperative complications and prognosis? World J Surg. 2018;42(9):2894\u2013901.","journal-title":"World J Surg."},{"issue":"2","key":"14936_CR12","doi-asserted-by":"publisher","first-page":"478","DOI":"10.1016\/j.ejso.2016.11.015","volume":"43","author":"M Paireder","year":"2017","unstructured":"Paireder M, Asari R, Kristo I, et al. Impact of sarcopenia on outcome in patients with esophageal resection following neoadjuvant chemotherapy for esophageal cancer. Eur J Surg Oncol. 2017;43(2):478\u201384.","journal-title":"Eur J Surg Oncol."},{"issue":"2","key":"14936_CR13","doi-asserted-by":"publisher","first-page":"1175","DOI":"10.21873\/anticanres.14060","volume":"40","author":"CH Huang","year":"2020","unstructured":"Huang CH, Lue KH, Hsieh TC, Liu SH, Wang TF, Peng TC. Association between sarcopenia and clinical outcomes in patients with esophageal cancer under neoadjuvant therapy. Anticancer Res. 2020;40(2):1175\u201381.","journal-title":"Anticancer Res."},{"key":"14936_CR14","doi-asserted-by":"crossref","unstructured":"Yoon HG, Oh D, Ahn YC, et al. Prognostic impact of sarcopenia and skeletal muscle loss during neoadjuvant chemoradiotherapy in esophageal cancer. Cancers (Basel). 2020;12(4).","DOI":"10.3390\/cancers12040925"},{"issue":"13","key":"14936_CR15","doi-asserted-by":"publisher","first-page":"4445","DOI":"10.1245\/s10434-015-4558-4","volume":"22","author":"KW Reisinger","year":"2015","unstructured":"Reisinger KW, Bosmans JW, Uittenbogaart M, et al. Loss of skeletal muscle mass during neoadjuvant chemoradiotherapy predicts postoperative mortality in esophageal cancer surgery. Ann Surg Oncol. 2015;22(13):4445\u201352.","journal-title":"Ann Surg Oncol."},{"issue":"12","key":"14936_CR16","doi-asserted-by":"publisher","first-page":"1022","DOI":"10.1007\/s00595-019-01846-1","volume":"49","author":"N Kamitani","year":"2019","unstructured":"Kamitani N, Migita K, Matsumoto S, et al. Association of skeletal muscle loss with the long-term outcomes of esophageal cancer patients treated with neoadjuvant chemotherapy. Surg Today. 2019;49(12):1022\u20138.","journal-title":"Surg Today."},{"issue":"1","key":"14936_CR17","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1186\/s12957-018-1327-4","volume":"16","author":"T Jarvinen","year":"2018","unstructured":"Jarvinen T, Ilonen I, Kauppi J, Salo J, Rasanen J. Loss of skeletal muscle mass during neoadjuvant treatments correlates with worse prognosis in esophageal cancer: a retrospective cohort study. World J Surg Oncol. 2018;16(1):27.","journal-title":"World J Surg Oncol."},{"issue":"12","key":"14936_CR18","doi-asserted-by":"publisher","first-page":"3741","DOI":"10.1245\/s10434-017-6020-2","volume":"24","author":"S Mayanagi","year":"2017","unstructured":"Mayanagi S, Tsubosa Y, Omae K, et al. Negative impact of skeletal muscle wasting after neoadjuvant chemotherapy followed by surgery on survival for patients with thoracic esophageal cancer. Ann Surg Oncol. 2017;24(12):3741\u20137.","journal-title":"Ann Surg Oncol."},{"issue":"12","key":"14936_CR19","doi-asserted-by":"publisher","first-page":"6677","DOI":"10.21873\/anticanres.11278","volume":"36","author":"J Liu","year":"2016","unstructured":"Liu J, Motoyama S, Sato Y, et al. Decreased skeletal muscle mass after neoadjuvant therapy correlates with poor prognosis in patients with esophageal cancer. Anticancer Res. 2016;36(12):6677\u201385.","journal-title":"Anticancer Res."},{"issue":"9596","key":"14936_CR20","doi-asserted-by":"publisher","first-page":"1453","DOI":"10.1016\/S0140-6736(07)61602-X","volume":"370","author":"E von Elm","year":"2007","unstructured":"von Elm E, Altman DG, Egger M, Pocock SJ, G\u00f8tzsche PC, Vandenbroucke JP. The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. Lancet. 2007;370(9596):1453\u20137.","journal-title":"Lancet."},{"issue":"7","key":"14936_CR21","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1016\/S1470-2045(08)70153-0","volume":"9","author":"CM Prado","year":"2008","unstructured":"Prado CM, Lieffers JR, McCargar LJ, et al. Prevalence and clinical implications of sarcopenic obesity in patients with solid tumours of the respiratory and gastrointestinal tracts: a population-based study. Lancet Oncol. 2008;9(7):629\u201335.","journal-title":"Lancet Oncol."},{"issue":"5","key":"14936_CR22","doi-asserted-by":"publisher","first-page":"997","DOI":"10.1139\/H08-075","volume":"33","author":"M Mourtzakis","year":"2008","unstructured":"Mourtzakis M, Prado CM, Lieffers JR, Reiman T, McCargar LJ, Baracos VE. A practical and precise approach to quantification of body composition in cancer patients using computed tomography images acquired during routine care. Appl Physiol Nutr Metab. 2008;33(5):997\u20131006.","journal-title":"Appl Physiol Nutr Metab."},{"issue":"2","key":"14936_CR23","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1097\/01.sla.0000133083.54934.ae","volume":"240","author":"D Dindo","year":"2004","unstructured":"Dindo D, Demartines N, Clavien PA. Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey. Ann Surg. 2004;240(2):205\u201313.","journal-title":"Ann Surg."},{"issue":"10","key":"14936_CR24","doi-asserted-by":"publisher","first-page":"1266","DOI":"10.5858\/arpa.LGT200570","volume":"136","author":"TM Darragh","year":"2012","unstructured":"Darragh TM, Colgan TJ, Cox JT, et al. The Lower Anogenital Squamous Terminology Standardization Project for HPV-Associated Lesions: background and consensus recommendations from the College of American Pathologists and the American Society for Colposcopy and Cervical Pathology. Arch Pathol Lab Med. 2012;136(10):1266\u201397.","journal-title":"Arch Pathol Lab Med."},{"issue":"11","key":"14936_CR25","doi-asserted-by":"publisher","first-page":"2698","DOI":"10.1007\/s00268-016-3603-1","volume":"40","author":"BA Grotenhuis","year":"2016","unstructured":"Grotenhuis BA, Shapiro J, van Adrichem S, et al. Sarcopenia\/muscle mass is not a prognostic factor for short- and long-term outcome after esophagectomy for cancer. World J Surg. 2016;40(11):2698\u2013704.","journal-title":"World J Surg."},{"issue":"5","key":"14936_CR26","doi-asserted-by":"publisher","first-page":"998","DOI":"10.1007\/s00330-014-3110-4","volume":"24","author":"C Yip","year":"2014","unstructured":"Yip C, Goh V, Davies A, et al. Assessment of sarcopenia and changes in body composition after neoadjuvant chemotherapy and associations with clinical outcomes in oesophageal cancer. Eur Radiol. 2014;24(5):998\u20131005.","journal-title":"Eur Radiol."},{"issue":"5","key":"14936_CR27","doi-asserted-by":"publisher","first-page":"1359","DOI":"10.1007\/s00330-015-3963-1","volume":"26","author":"D Tamandl","year":"2016","unstructured":"Tamandl D, Paireder M, Asari R, Baltzer PA, Schoppmann SF, Ba-Ssalamah A. Markers of sarcopenia quantified by computed tomography predict adverse long-term outcome in patients with resected oesophageal or gastro-oesophageal junction cancer. Eur Radiol. 2016;26(5):1359\u201367.","journal-title":"Eur Radiol."},{"issue":"5","key":"14936_CR28","doi-asserted-by":"publisher","first-page":"808","DOI":"10.21037\/jgo.2017.06.11","volume":"8","author":"GZ Murimwa","year":"2017","unstructured":"Murimwa GZ, Venkat PS, Jin W, et al. Impact of sarcopenia on outcomes of locally advanced esophageal cancer patients treated with neoadjuvant chemoradiation followed by surgery. J Gastrointest Oncol. 2017;8(5):808\u201315.","journal-title":"J Gastrointest Oncol."},{"issue":"7","key":"14936_CR29","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1007\/BF02982704","volume":"12","author":"Y Rolland","year":"2008","unstructured":"Rolland Y, Czerwinski S, Abellan Van Kan G, et al. Sarcopenia: its assessment, etiology, pathogenesis, consequences and future perspectives. J Nutr Health Aging. 2008;12(7):433\u201350.","journal-title":"J Nutr Health Aging."},{"issue":"4","key":"14936_CR30","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1007\/s00198-009-1059-y","volume":"21","author":"T Lang","year":"2010","unstructured":"Lang T, Streeper T, Cawthon P, Baldwin K, Taaffe DR, Harris TB. Sarcopenia: etiology, clinical consequences, intervention, and assessment. Osteoporos Int. 2010;21(4):543\u201359.","journal-title":"Osteoporos Int."},{"issue":"2","key":"14936_CR31","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1093\/ajcn\/82.2.428","volume":"82","author":"M Cesari","year":"2005","unstructured":"Cesari M, Kritchevsky SB, Baumgartner RN, et al. Sarcopenia, obesity, and inflammation\u2013results from the trial of angiotensin converting enzyme inhibition and novel cardiovascular risk factors study. Am J Clin Nutr. 2005;82(2):428\u201334.","journal-title":"Am J Clin Nutr."},{"issue":"3","key":"14936_CR32","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1515\/hsz-2012-0247","volume":"394","author":"R Calvani","year":"2013","unstructured":"Calvani R, Joseph AM, Adhihetty PJ, et al. Mitochondrial pathways in sarcopenia of aging and disuse muscle atrophy. Biol Chem. 2013;394(3):393\u2013414.","journal-title":"Biol Chem."},{"issue":"1","key":"14936_CR33","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1016\/j.clnu.2011.08.008","volume":"31","author":"S Awad","year":"2012","unstructured":"Awad S, Tan BH, Cui H, et al. Marked changes in body composition following neoadjuvant chemotherapy for oesophagogastric cancer. Clin Nutr. 2012;31(1):74\u20137.","journal-title":"Clin Nutr."},{"issue":"3","key":"14936_CR34","doi-asserted-by":"publisher","first-page":"724","DOI":"10.1016\/j.clnu.2015.05.011","volume":"35","author":"P Anandavadivelan","year":"2016","unstructured":"Anandavadivelan P, Brismar TB, Nilsson M, Johar AM, Martin L. Sarcopenic obesity: a probable risk factor for dose limiting toxicity during neo-adjuvant chemotherapy in oesophageal cancer patients. Clin Nutr. 2016;35(3):724\u201330.","journal-title":"Clin Nutr."},{"issue":"3","key":"14936_CR35","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1016\/j.ejso.2014.11.040","volume":"41","author":"BH Tan","year":"2015","unstructured":"Tan BH, Brammer K, Randhawa N, et al. Sarcopenia is associated with toxicity in patients undergoing neo-adjuvant chemotherapy for oesophago-gastric cancer. Eur J Surg Oncol. 2015;41(3):333\u20138.","journal-title":"Eur J Surg Oncol."},{"issue":"6","key":"14936_CR36","doi-asserted-by":"publisher","first-page":"748","DOI":"10.1093\/ageing\/afu115","volume":"43","author":"AJ Cruz-Jentoft","year":"2014","unstructured":"Cruz-Jentoft AJ, Landi F, Schneider SM, et al. Prevalence of and interventions for sarcopenia in ageing adults: a systematic review. Report of the International Sarcopenia Initiative (EWGSOP and IWGS). Age Ageing. 2014;43(6):748\u201359.","journal-title":"Age Ageing."},{"issue":"2","key":"14936_CR37","first-page":"doz030","volume":"33","author":"K Liu","year":"2020","unstructured":"Liu K, Ji S, Xu Y, et al. Safety, feasibility, and effect of an enhanced nutritional support pathway including extended preoperative and home enteral nutrition in patients undergoing enhanced recovery after esophagectomy: a pilot randomized clinical trial. Dis Esophagus. 2020;33(2):doz030.","journal-title":"Dis Esophagus."},{"issue":"1","key":"14936_CR38","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1002\/jcsm.13126","volume":"14","author":"P Fang","year":"2022","unstructured":"Fang P, Zhou J, Xiao X, et al. The prognostic value of sarcopenia in oesophageal cancer: a systematic review and meta-analysis. J Cachexia Sarcopenia Muscle. 2022;14(1):3\u201316.","journal-title":"J Cachexia Sarcopenia Muscle."}],"container-title":["Annals of Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-024-14936-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1245\/s10434-024-14936-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-024-14936-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,7]],"date-time":"2024-05-07T09:03:00Z","timestamp":1715072580000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1245\/s10434-024-14936-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1,20]]},"references-count":38,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2024,6]]}},"alternative-id":["14936"],"URL":"https:\/\/doi.org\/10.1245\/s10434-024-14936-3","relation":{},"ISSN":["1068-9265","1534-4681"],"issn-type":[{"value":"1068-9265","type":"print"},{"value":"1534-4681","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,1,20]]},"assertion":[{"value":"16 August 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 January 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 January 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The Institutional Review Board (IRB) of West China hospital approved our study (IRB no. 2022-853), and the writing of informed consent was waived.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical standards"}}]}}